MJBizDaily International Newsletter

Get our international newsletter

We value your Privacy.
More Exclusive Features

Brazil again delays vote on regulating cannabis cultivation and products registration, dealing further setback to open market

Published October 15, 2019 | By Alfredo Pascual

Brazilian health regulators unexpectedly postponed another vote on a groundbreaking proposal to regulate the cultivation and registration of cannabis-based medicines, delivering a further blow to efforts to open up fresh business opportunities in Latin America’s largest medical cannabis market. The directory of the Brazilian Agência Nacional de Vigilância Sanitária – or National Sanitary Surveillance Agency […]

Read More

France appears ready to OK funding for a medical cannabis experiment with 3,000 patients

Published October 14, 2019 | By Alfredo Pascual

French lawmakers appear ready to approve legislation to bankroll a two-year medical cannabis trial program for 3,000 patients, a move that would give overseas companies the opportunity to export product to what could become one of Europe’s largest markets. Olivier Véran, deputy of the French National Assembly, submitted an amendment to the Social Security Financing Bill (Projet de […]

Read More

‘It’s confounding’: Former Nova Scotia premier wants Ottawa to fix cannabis banking problems

Published October 11, 2019 | By Matt Lamers

Former Nova Scotia Premier Darrell Dexter is calling on the federal government to address banking issues stymieing legal marijuana businesses across Canada. Almost one year into adult-use legalization, cannabis entrepreneurs and registered not-for-profit trade associations are accusing Canada’s banking sector of gouging and arbitrarily closing bank accounts – sometimes citing U.S. federal law that prohibits marijuana. […]

Read More

Hexo, Green Organic Dutchman’s woes may be a harbinger for Canadian cannabis businesses, analysts say

Published October 10, 2019 | By Matt Lamers

Some Canadian cannabis companies are facing a financial squeeze because of the country’s slow rollout of recreational marijuana stores and a dwindling pool of available funding. Quebec cannabis producer Hexo Corp.’s lower fourth-quarter revenue projection and Ontario-based The Green Organic Dutchman’s capital issues could be a sign of things to come for companies with unduly […]

Read More

Analysis: German sales of insured medical cannabis soar in second quarter

Published October 9, 2019 | By Alfredo Pascual

Sales of medical cannabis covered by insurance continue to increase in Germany, reaching new highs in the second quarter, according to newly released data. The steady growth in sales in the world’s largest importer of medical marijuana is a good sign for the global industry, and it comes as several countries are gearing up to start large-scale […]

Read More

Citing ‘consistent failure,’ Aleafia nixes cannabis supply deal with Aphria

Published October 8, 2019 | By Matt Lamers

Toronto marijuana company Aleafia Health intends to cancel a supply agreement with Aphria, citing a “consistent failure” to meet its obligations to provide cannabis. The industry has grappled with supply issues since legalization, but until now, few companies have taken action over contractual shortfalls. The dispute between the Ontario-based companies could therefore be a sign of […]

Read More